K2M Group Holdings Inc (KTWO) Receives $24.44 Consensus Price Target from Analysts
K2M Group Holdings Inc (NASDAQ:KTWO) has been given an average rating of “Buy” by the fourteen research firms that are currently covering the company, Marketbeat reports. One analyst has rated the stock with a sell recommendation, three have assigned a hold recommendation and nine have given a buy recommendation to the company. The average 12 month price target among analysts that have covered the stock in the last year is $24.44.
Several brokerages have issued reports on KTWO. Zacks Investment Research raised K2M Group from a “sell” rating to a “hold” rating in a research note on Thursday, January 25th. Oppenheimer set a $24.00 price target on K2M Group and gave the company a “buy” rating in a research note on Thursday. Barclays reissued a “buy” rating and issued a $25.00 price target on shares of K2M Group in a research note on Tuesday, January 9th. Needham & Company LLC boosted their price target on K2M Group from $20.00 to $23.00 and gave the company a “buy” rating in a research note on Tuesday, January 9th. Finally, BidaskClub raised K2M Group from a “hold” rating to a “buy” rating in a research report on Wednesday, January 10th.
Shares of K2M Group (NASDAQ:KTWO) traded up $0.01 on Wednesday, reaching $19.35. The company’s stock had a trading volume of 255,827 shares, compared to its average volume of 310,832. K2M Group has a 12-month low of $16.44 and a 12-month high of $25.99. The company has a current ratio of 2.84, a quick ratio of 1.52 and a debt-to-equity ratio of 0.30.
Several large investors have recently modified their holdings of KTWO. Penn Capital Management Co. Inc. raised its position in shares of K2M Group by 277.7% during the fourth quarter. Penn Capital Management Co. Inc. now owns 581,033 shares of the medical device company’s stock worth $10,470,000 after purchasing an additional 427,208 shares during the period. Elk Creek Partners LLC purchased a new stake in K2M Group in the 3rd quarter valued at $7,836,000. Gabelli Funds LLC raised its position in K2M Group by 1,587.1% in the 4th quarter. Gabelli Funds LLC now owns 308,733 shares of the medical device company’s stock valued at $5,557,000 after buying an additional 290,433 shares during the last quarter. Sectoral Asset Management Inc raised its position in K2M Group by 29.9% in the 4th quarter. Sectoral Asset Management Inc now owns 1,164,412 shares of the medical device company’s stock valued at $20,959,000 after buying an additional 267,698 shares during the last quarter. Finally, State Street Corp raised its position in K2M Group by 39.8% in the 2nd quarter. State Street Corp now owns 713,257 shares of the medical device company’s stock valued at $17,378,000 after buying an additional 203,067 shares during the last quarter. 99.99% of the stock is currently owned by institutional investors.
About K2M Group
K2M Group Holdings, Inc is a medical device company focused on designing, developing and commercializing spine and minimally invasive technologies and techniques. The Company’s solutions are focused on achieving three-dimensional Total Body Balance. Its spine products are used by spine surgeons to treat spinal pathologies, such as deformity (primarily scoliosis), trauma and tumor.
Receive News & Ratings for K2M Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for K2M Group and related companies with MarketBeat.com's FREE daily email newsletter.